The failure of many potential candidates during clinical trials significantly impacts the cost of drug development. Computational drug design has the means to lower these costs by allowing not only ...

CAMBRIDGE, England--(BUSINESS WIRE)--DeepMirror, a University of Cambridge spin-out company developing intuitive design software for the discovery of novel therapeutic drugs, today announced the ...

Back in 1996, a paper came out that has been cited time and time again. In a footnote to a figure caption, Regine S. Bohacek, Colin McMartin, and Wayne C. Guida of Ciba-Geigy estimated that at least ...

Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...

The biopharmaceutical industry stands on the cusp of a revolution, with artificial intelligence (AI) emerging as a transformative force in drug development. AI's ability to reduce the time and cost of ...